Key Highlights

  • Net sales were USD 1,540 million, up 3%, as a 5% pricing gain offset a 2% Volume decline.
  • Net income attributable was USD 196 million, or USD 1.29 per diluted share, versus USD 46 million, or USD 0.31.
  • Adjusted EBITDA rose 6% to USD 200 million, and adjusted EPS was USD 0.21 versus USD 0.17.
  • A USD 150 million PFAS insurance receipt reduced selling, general and administrative expense in the quarter.

Results

The Chemours Company (NYSE:CC) reported third-quarter 2026 net sales of USD 1,540 million, up 3% from USD 1,495 million and down 3% from USD 1,591 million in the second quarter. Pricing rose 5%, mainly from previously announced Titanium Technologies price actions and a favorable mix shift toward Advanced Performance Materials Performance Solutions, while volumes fell 2%, reflecting lower North American stationary air conditioning aftermarket sales of Opteon blends against elevated prior-year demand.

Net income attributable was USD 196 million, or USD 1.29 per diluted share, versus USD 46 million, or USD 0.31, and a loss of USD 274 million, or USD 1.81, in the second quarter. Adjusted Net Income was USD 31 million, or USD 0.21 per share, versus USD 26 million, or USD 0.17.

Drivers

Net income included the receipt of USD 150 million of PFAS insurance proceeds under an agreement tied to finalizing the judicial consent order with the State of New Jersey, presented as a reduction in selling, general and administrative expense. Adjusted EBITDA was USD 200 million versus USD 189 million a year earlier and USD 247 million in the second quarter, driven by Titanium Technologies pricing and growth in Performance Solutions.

Management cited roughly 10% year-over-year pricing in Titanium Technologies and 26% growth in Advanced Performance Materials Performance Solutions, supported by Demand in AI infrastructure, Data Center and semiconductor end markets.

The Thermal and Specialized Solutions segment had net sales of USD 510 million, down 9%, on a 9% volume decline, with Opteon refrigerants at USD 287 million (down 22%), Freon at USD 100 million (up 6%) and foam, propellants and other at USD 123 million (up 26%). Its adjusted EBITDA fell 30% to USD 136 million, a 27% Margin versus 35%. Titanium Technologies net sales rose 11% to USD 680 million, with TiO2 pigment at USD 650 million (up 10%) and minerals at USD 30 million (up 43%).

Legal, Portfolio and Product Moves

The company settled with the State of North Carolina and 11 local entities, resolving litigation over PFAS and other historical discharges from Fayetteville Works and claims of PFAS contamination unrelated to that site, including from AFFF use. It completed the sale of the Kuan Yin property for total net consideration of about USD 340 million, including USD 56 million of gross proceeds for the remaining land parcel. Restricted cash was about USD 103 million, mostly the PFAS Insurance Escrow.

Chemours formally launched its liquid cooling portfolio under the Faizeon brand, with four two-phase direct-to-chip fluids and one immersion cooling fluid. President and chief executive Denise Dignam said the company continues to navigate stationary aftermarket dynamics and a softer macroeconomic environment.

Factors to Watch Into 2027

Items to watch include TiO2 pricing, aftermarket demand in Thermal and Specialized Solutions, liquid cooling adoption and PFAS-related payments.